Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC728705 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEP170P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129617 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01226 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR6883 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGDR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZBED4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HFE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLYR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPPR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TENM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on